MILWAUKEE, March 28, 2023 – The Dohmen Company Foundation announced today the appointment of Michael Italiano as Chief Financial and Chief Investment Officer. Italiano will be responsible for managing the Dohmen Impact Investment Fund and fiscal operations for the Foundation.
“Michael’s impressive career experience, successful track record, high integrity, and years of dedication to Dohmen make him an ideal fit for overseeing the Foundation’s financial matters and the newly created Dohmen Impact Investment Fund,” said Foundation CEO and President Rachel Roller.
Last week the Foundation announced the launch of the Impact Fund during a live-streamed event hosted at the White House that highlighted leading organizations actively engaged in the President’s bold goal of ending hunger and reducing diet-related diseases by 2030. The Impact Fund will invest $60 million to accelerate the growth and impact of for-profit social enterprises advancing proven food solutions that improve human health. The Impact Fund will assist five to ten for-profit companies whose efforts are in alignment with the Foundations values and vision. 100% of financial profits achieved through Impact Fund investments will fuel the foundation’s charitable giving activities and public awareness strategies.
“I’m excited that we’ll be working to identify and support ground-breaking food solutions,” said Italiano. “In addition, we’re focused on achieving more than just return on our invested capital. We’re measuring success based on social return.”
“The Dohmen Impact Investment Fund builds upon the Dohmen Company’s impressive 165-year business legacy,” said Roller. “We are advancing a self-sustaining, high-impact business model within the philanthropic sector, with a triple aim of supporting proven healthy food solutions grow their impact, increasing consumer access to healthy food, and supporting the non-profit food and nutrition ecosystem through grant making, made possible from profits through our Impact Fund investments.”
Italiano joined Dohmen in 2009 after a prestigious career as a financial and corporate development executive for multiple Fortune 500 and life science companies including Deloitte, Kimberly Clark, Cooper Power Systems, and Schwarz Pharma. He originally served as Corporate Development Officer and then as the CFO for the Dohmen Company, providing growth through strategic acquisitions, culminating with the successful integration, double-digit growth, and ultimate divestiture of what became Dohmen Life Sciences, now Eversana. Following this divestiture, Michael was instrumental in the conversion of Dohmen from a multi-generational family-owned business to an organization wholly owned by a private foundation. A graduate of the University of Wisconsin Whitewater, and received his MBA from the University of North Carolina.